Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension (PH)”

146 trials

Showing 20 of 146 results

Large-scale testing (Phase 3)Looking for participantsNCT07288398
What this trial is testing

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Who this might be right for
Pulmonary Hypertension Associated With HFpEF
Tenax Therapeutics, Inc. 540
Testing effectiveness (Phase 2)Ended earlyNCT01065051
What this trial is testing

Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics

Who this might be right for
Hypertension, PulmonaryVentricular Dysfunction, Left
Bayer 1
Not applicableStudy completedNCT00675051
What this trial is testing

Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
University of California, San Francisco 20
Testing effectiveness (Phase 2)Study completedNCT04945460
What this trial is testing

Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

Who this might be right for
Hypertension, Pulmonary
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 164
Not applicableStudy completedNCT05496504
What this trial is testing

Pulmonary Hypertension and Arrhythmia

Who this might be right for
Pulmonary Hypertension
Asklepios Neurological Clinic Bad Salzhausen 222
Testing effectiveness (Phase 2)UnknownNCT04055415
What this trial is testing

Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Liaocheng People's Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06475781
What this trial is testing

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD

Who this might be right for
Group 3 Pulmonary Hypertension
Foresee Pharmaceuticals Co., Ltd. 126
Testing effectiveness (Phase 2)Study completedNCT03015402
What this trial is testing

Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction

Who this might be right for
Pulmonary Hypertension SecondaryHeart Failure
University of Pittsburgh 33
Not applicableLooking for participantsNCT07311044
What this trial is testing

CVD/PH and Voice Characteristics

Who this might be right for
Pulmonary HypertensionCardiovascular Diseases
Mayo Clinic 7,000
Testing effectiveness (Phase 2)Study completedNCT03814317
What this trial is testing

Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension

Who this might be right for
SarcoidosisPrecapillary Pulmonary HypertensionInterstitial Lung Disease
University of Florida 5
Not applicableStudy completedNCT03667794
What this trial is testing

Evaluation of Novel Lung Function Parameters in Patients With Pulmonary Hypertension (PH)

Who this might be right for
Pulmonary Hypertension
Universitätsmedizin Mannheim 75
Post-approval studies (Phase 4)Study completedNCT02742909
What this trial is testing

Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease

Who this might be right for
Pulmonary Hypertension
LI ZHAO 9
Testing effectiveness (Phase 2)Ended earlyNCT03924154
What this trial is testing

RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)

Who this might be right for
Pulmonary Arterial Hypertension
Altavant Sciences GmbH 3
Large-scale testing (Phase 3)Enrolling By InvitationNCT07436689
What this trial is testing

Long-Term Open-Label Extension Study of Oral Levosimendan

Who this might be right for
Pulmonary Hypertension Associated With HFpEF
Tenax Therapeutics, Inc. 800
Not applicableAvailableNCT05356052
What this trial is testing

Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon
Testing effectiveness (Phase 2)Study completedNCT02216279
What this trial is testing

Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
Montreal Heart Institute 45
Early research (Phase 1)Study completedNCT04370873
What this trial is testing

Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006)

Who this might be right for
Pulmonary Hypertension
Merck Sharp & Dohme LLC 22
Large-scale testing (Phase 3)Ended earlyNCT00313196
What this trial is testing

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)

Who this might be right for
Pulmonary Hypertension
Actelion 12
Testing effectiveness (Phase 2)Study completedNCT00694850
What this trial is testing

Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)

Who this might be right for
Hypertension, Pulmonary
Bayer 22
Not applicableStudy completedNCT01948518
What this trial is testing

Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease

Who this might be right for
Diffuse Parenchymal Lung DiseasePulmonary Hypertension
The Cleveland Clinic 15
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation